Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on November 16, 2020. The filing reports a corporate governance event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a board appointment.
Material Changes
The material change reported is the appointment of a new director to the Board of Directors.
Management Commentary and Corporate Actions
- Appointment: Rich Nelson was appointed as a member of the Board of Directors, effective immediately on November 16, 2020.
- Term: Mr. Nelson will serve through the date of the next annual meeting of stockholders.
- Background: Mr. Nelson is a Senior Vice President of Vericast Corp., an entity wholly-owned by MacAndrews & Forbes Incorporated, a related party to the Company.
- Compensation: Mr. Nelson will not receive compensation for his board service due to his existing employment with a MacAndrews & Forbes entity.
- Committee Assignments: As of the filing date, Mr. Nelson has not been appointed to any Board committees.
Investor Verification Checklist
- Verify the relationship between vTv Therapeutics and MacAndrews & Forbes Incorporated.
- Confirm the date of the next annual meeting of stockholders to determine the end of Mr. Nelson's term.
- Review future filings for any committee assignments given to the new director.